1. Đơng thị Hồi An, Cao Minh Nga (2003), Kỹ thuật định tip gene siêu vi viêm gan B bằng Multiplex PCR trên bệnh nhân nhiễm siêu vi viêm gan B mạn, Từ khoa học sinh học phân tử đến cuộc sống và chăm sĩc sức khỏe, tr. 17-25.
2. Báo “ Y học phổ thơng dành cho mọi người”, chuyên đề Gan và Mật (6/2009), trang 8-11.
3. Bio- Rad Laboratories. Inc, Hướng dẫn sử dụng Real- Time PCR.
4. Bùi Hữu Hồng (2002), Đặc điểm của dấu ấn huyết thanh và kiểu gene của virus viêm gan B trên bệnh nhân xơ gan và ung thư gan, Luận văn tốt nghiệp trường đại học Khoa học Tự nhiên thành phố Hồ Chí Minh.
5. Trịnh Quân Huấn (2006), Bệnh viêm gan do virus, Nhà xuất bản y học, tr. 25- 75.
6. Trần Thiện Tồn (2009), Xây dựng quy trình phát hiện đột biến rtA181/V kháng ADEFOVIR của HBV bằng phương pháp PCR trên bệnh nhân nhiễm HBV mạn tính ở Việt Nam, Luận văn tốt nghiệp trường đại học Khoa học Tự nhiên thành phố Hồ Chí Minh.
7. Nguyễn thị Minh Thư, Phạm Hùng Vân (2005), Định type và phát hiện đột biến kháng Lavumidine của virus viêm gan B bằng kỹ thuật giải trình tự, từ nguồn www. drthuthuỵcom.
8. Phạm văn Tỵ (2005), Virus học, Virus Hepadna Họ Hepadnavirus, trang 152. 9. Phạm Hùng Vân (2009), PCR và real-time PCR, các vấn đề cơ bản và các áp dụng thường gặp, Nhà xuất bản y học, trang 9-10.
Tài liệu tiếng Anh
10. Alfredo Alberti, Roberto Ẹ Jordi B. (2003), East internationalconsensus conference on Hepatitis B virus, J. of Hepatology, v. 39, p. 3-25.
11. Arankalle V.Ạ, Murhekar K.M., Gandhe S.S., Murhekar M.V., Ramdasi ẠỴ, Padbidri V.S., et al (2003), Hepatitis B virus: predominance of geneotype D in primitive tribes of the Andaman and Nicobar islands, India (1989-1999), J. Gene Virol, v. 84, p. 1915-1920.
12. Buti M., Cotrina M., Valdes Ạ, Jardi R., Rodriguez-Frias F., Esteban R. (2002), Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudinẻ, J. Hepatol, v. 36, p. 445-446.
13. Chien R.N., Yeh C.T., Tsai S.L., Chu C.M., Liaw ỴF .(2003), Determinants for sustained HBeAg response to lamivudine therapy, Hepatology, v. 38, p. 1267-1273.
14. Chu C.J., Hussain M., Lok ẠS. (2002), Hepatitis B virus geneotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus geneotype C, v. 122, p. 1756-1762.
15. Chu C.J., Keeffe ẸB., Han S.H., Perrillo R.P., Min ẠD., Soldevila-Pico C. (2003), Prevalence of HBV precore/core promoter variants in the United States, Hepatology, v. 38, p. 619-628.
16. Chu C.J., Lok ẠS. (2005), Hepatitis B virus geneotype and molecular variants.
17. Christoph seeger, William S.Meson (2000), Hepatitis B virus Biology, Micro and Molecular Biology Reviews, v. 64 (1), p. 51-68.
18. Devarbhavi H.C., Cohen ẠJ., Patel R., Wiesner R.H., Dickson R.C., Ishitani M.B. (2002), Preliminary results: outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus geneotype, Liver Transpl, v. 8, p. 550-555. 19. Ding X., Mizokami M., Yao G., Xu B., Orito Ẹ, Ueda R. (2001), Hepatitis B virus geneotype distribution among chronic hepatitis B virus carriers in Shanghai Chin, Intervirology, v. 44, p. 43-47.
20. Erhardt Ạ, Reineke Ụ, Blondin D., Gerlich W.H., Adams Ọ, Heintges T. (2000), Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B, Hepatology, v. 31, p. 716-725.
21. Garfein R.S., Bower W.Ạ, Loney C.M., Hutin ỴJ., Xia G.L., Jawanda J. (2004), Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B, Hepatology, v. 40, p. 865- 873.
22. Girlanda R., Mohsen ẠH., Smith H., Sablon Ẹ, Yuen M.F., ĨGrady J. (2004), Hepatitis B virus geneotype A and D and clinical outcomes of liver transplantation for HBV-related disease, Liver Transp, v. 10, p. 58-64.
23. Grandjacques C., Pradat P., Stuyver L., Chevallier M., Chevallier P., Pichoud C. (2000), Rapid detection of geneotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus geneome: correlation with viral persistence and disease severity, J Hepatol, v. 33, p. 430-439.
24. Janssen H.L., Flink H.J., Zonneveld M.V., Niesters H.G., Man R.ẠD., Schalm SW (2004), HBeAg seroconversion in chronic HBV patients treated with pegylated interferon alfa-2b alone or in combination with lamivudine: the role of HBV geneotype, Hepatology, v. 40, p. 660Ạ
25. Kao J.H, Chen P.J, Lai M.Y, Chen D.S. (2000), Hepatitis B geneotypes correlate with clinical outcomes in patients with chronic hepatitis B, Gastroenterology, v. 118, p. 554-559.
26. Kao J.H., Liu C.J., Chen D.S. (2002), Hepatitis B viral geneotypes and lamivudine resistanc, J Hepatol, v. 36, p. 303-304.
27. Kumar Ạ, Kumar S.Ị, Pandey R., Naik ., Aggarwal R. (2005), Hepatitis B virus geneotype A is more often associated with severe liver disease in northern India than is geneotype D, Indian J Gastroenterol, v. 24, p. 19-22.
28. Lindh M., Hannoun ., Dhillon ẠP, Norkrans G., Horal P. (1999), Core promoter mutations and geneotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers, J Infect Dis 1999, v. 179, p. 775-782.
29. Mamun-Al Mahtab, Salimur Rahman, Mobin Khan and Fazal Karim (2008),
Hepatitis B virus geneotypes: an overview, Hepatobiliary Pancreat Dis Int.
30. Mayerat C., Mantegani Ạ, Frei P.C. (1999), Does hepatitis B virus (HBV) geneotype influence the clinical outcome of HBV infection?, J Viral Hepat, v. 6, p. 299-304.
31. Norio Akuta and Hiromitsu Kumada (2005), Influence of hepatitis B virus
geneotypes on the response to antiviral therapies, Journal of Antimicrobial
Chemotherapy, v. 55, p. 139–142.
32. Rodriguez-Frias F., Buti M., Jardi R., Cotrina M., Viladomiu L., Esteban R. (1995), Hepatitis B virus infection: precore mutants and its relation to viral geneotypes and core mutations, Hepatology, v. 22, p. 1641-1647.
33. Sakugawa H., Nakasone ., Nakayoshi T., Orito Ẹ, Mizokami M., Yamashiro T (2002), Preponderance ofhepatitis B virus geneotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan, J Med Virol, v. 67, p. 484-489.
34. Sánchez-Tapias J.., Costa J., Mas Ạ, Bruguera M., Rodes J. (2002),
Influence of hepatitis B virus geneotype on the longterm outcome of chronic hepatitis B in western patients, Gastroenterology, v. 123, p. 1848-1856.
35. Shiina S., Fujino ., Uta ., Tagawa K., Unuma T., Yoneyama M. (1991),
Relationship of HBeAg subtypes with HBeAg/anti-HBe status and chronic liver disease Part I: Analysis of 1744 HBeAg carriers, Am J Gastroenterol, v. 86, p. 866-871.
36. Sumi H., Yokosukạ, Seki N., Arai ., Imazeki ., Kurihara T. (2003), Influence of hepatitis B virus geneotypes on the progression of chronic type B liver disease, Hepatology, v. 7, p. 19-26.
37. Thakur V., Sarin S.K., Rehman S., Guptan R.C, Kazim S.N, Kumar S. (2005), Role of HBV geneotype in predicting response to lamivudine therapy in patients with chronic hepatitis B, Indian J Gastroenterol, v. 24, p. 12-15.
38.Tania M. Welzel, Wendell J. Miley, Thomas L. Parks, Jame J.Goedert, Denise Whitby, and Betty ẠOrtiz-Conde (2006), Real- Time PCR Assay for Direction and Quantification of Hepatitis B Virus Geneotypes A to G, Journal of clinical microbiology, p. 3325-3333.
39. Wai C.T., Chu C.J., Hussain M., Lok ẠS. (2002), HBV geneotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than geneotype C, Hepatology, v. 36, p. 1425-1430.
40. Wai-Kuo Shhih, Ling C.Cheung, Harvey J.Alter, leo M.lee and Jianren Gu (1991), Strain Analysis of Hepatitis B Virus on the Basis of Restriction Endonuclease Analysis of Polymerase Chain Reaction products, Journal of clicnical microbiology, p. 1640-1644.
41. William M., Lee (1997) “Haepatitis B virus infection” Medical aprogress 337, v. 24, p. 1733-1745.
42. Westland C., Delaney W., Yang H., Chen S.S., Marcellin P., Hadziyannis S. (2003), Hepatitis B virus geneotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1, Gastroenterology, v. 125, p. 107-116.
43. Xin Ding, Hongxi Gu (2003), “Molecular epidemiology of Hepatitis virus and Geneotypic distribution Hepatitis B and C virus in Harbin China”
Jpn.J.Infect.Dis, p. 19-22.
44. Yuen M.F., Sablon Ẹ, Yuan H.J, Wong D.K. (2003), Significance of hepatitis B geneotypein acute exacerbation, HBeAg seroconversion, cirrhosis- related complications,and hepatocellular carcinoma, Hepatology, p. 37:562. 45. Zollner B., Petersen J., Puchhammer-Stuckl Ẹ, Kletzmayr J., Sterneck M., Fischer L. (2004), Viral features of lamivudine resistant hepatitis B geneotypes A and D. Hepatology, v. 39, p. 42-50. Internet 46. http.//www.whọint/mediacentre/factsheets/fs204/en/. 47. http.//vịwikipediạorg/wiki/Vi%C3%Aam_gan_si%C3%AAu_vi_B.
